Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2010
12/23/2010WO2010147776A1 Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones
12/23/2010WO2010146488A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/23/2010WO2010145197A1 Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors
12/23/2010US20100324302 Processes for making epothilone compounds and analogs
12/23/2010US20100324043 Bicyclic And Tricyclic Compounds As KAT II Inhibitors
12/23/2010US20100324030 5-Quinoline derivatives having an anti-bacterial activity
12/23/2010US20100324029 Therapeutic agents
12/23/2010US20100322901 5, 6-ring annulated indole derivatives and use thereof
12/23/2010CA2763960A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/22/2010EP2264038A1 Optically active dibenzazepine derivatives
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2262814A1 4'4'-dioxaspiro-spirocyclically substituted tetramates
12/22/2010EP1392696B1 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro 2,3-b quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide
12/22/2010CN1988907B Dual small molecule inhibitors of cancer and angiogenesis
12/22/2010CN101925595A Phthalazinone derivatives
12/22/2010CN101921347A Hyaluronic acid derivative and drug containing the same
12/22/2010CN101921279A Spirocyclic heterocyclic derivatives and methods of their use
12/22/2010CN101475575B Extraction of tetraodontoxin, and preparation thereof used in drug dependence of dolantin
12/22/2010CN101128467B New synthesis of a camptothecin subunit
12/21/2010US7855294 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
12/21/2010US7855293 Fluorescent dyes such as 2-(4-acetanilino-1,3-butadieneyl)-3-spiro-1'-cyclohexan-1-(4-sulfobutyl)-3H -indolium hydroxide metal salts which couple biological materials without loss of fluorescence due to self-quenching
12/21/2010US7855194 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/21/2010CA2406255C Hydroxylamine esters as polymerization initiators
12/16/2010WO2010144571A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
12/16/2010WO2010144386A2 Antimicrobial polymers
12/16/2010WO2010143733A1 Novel fused cyclic compound and use thereof
12/16/2010WO2010143664A1 Tetracyclic compound
12/16/2010WO2010142836A1 Synthesis of ttx intermediates
12/16/2010WO2010142572A1 Sterically hindered amine stabilizers
12/16/2010WO2010052569A3 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
12/16/2010WO2009144555A8 Pyrazolospiroketone acetyl-coa carboxylase inhibitors
12/16/2010US20100317668 Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
12/16/2010US20100317628 MicroRNA Modulators and Method for Identifying and Using the Same
12/16/2010US20100317568 Anti-Viral Compounds
12/16/2010CA2802316A1 Synthesis of ttx intermediates
12/16/2010CA2764808A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
12/16/2010CA2764653A1 Tetracyclic compounds
12/16/2010CA2762930A1 Sterically hindered amine stabilizers
12/15/2010EP2261226A1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
12/15/2010EP2261208A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/15/2010EP2261207A1 Intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/15/2010EP2260042A1 Substituted spirocyclic cyclohexane derivatives
12/15/2010EP2260041A2 Cephalotaxus esters, methods of synthesis, and uses thereof
12/15/2010EP1866292B1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/15/2010EP1594873B1 Pyrrolidinohydrochinazolines
12/15/2010CN101918411A Process for the preparation of asenapine and intermediate products used in said process
12/15/2010CN101918365A Inhibitors of human immunodeficiency virus replication
12/15/2010CN101914102A Derivative L of rhodamine B, preparation thereof and use thereof
12/15/2010CN101318964B Novel crystal system of irinotecan hydrochloride and preparation method thereof
12/15/2010CN101255132B 6-aryl-3-substituted methylene-pyridinone derivatives and uses thereof
12/14/2010US7851478 Agent for preventing and/or treating movement disorder
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2430909C Inhibitors of papilloma virus
12/14/2010CA2347100C Novel indenoisoquinolines as antineoplastic agents
12/09/2010WO2010140802A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/09/2010WO2010140339A1 Heterocyclic compound
12/09/2010WO2010139717A1 New compounds
12/09/2010WO2010139657A1 Substituted pyrazine (thio)pyrans with a herbicidal action
12/09/2010WO2010084499A9 Bicyclic heterocyclic spiro compounds
12/09/2010US20100311976 Process for preparing tetrahydroquinoline derivatives
12/09/2010US20100311784 Stereoselective process and crystalline forms of a camptothecin
12/09/2010US20100311783 Stereoselective process and crystalline forms of a camptothecin
12/09/2010US20100311779 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
12/09/2010US20100311735 Inhibitors of human immunodeficiency virus replication
12/09/2010US20100311734 Spiro Compounds Useful as Antagonists of the H1 Receptor
12/08/2010EP2258776A1 Fluorescent cyanine dyes containing functional groups
12/08/2010EP2258703A1 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2257553A1 Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
12/08/2010EP2257170A1 Tetrahydrofuropyridones
12/08/2010CN101910179A (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid
12/08/2010CN101910165A Thiazole derivatives as protein kinase inhibitors
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910151A Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
12/08/2010CN101910142A Modulators for amyloid beta
12/08/2010CN101468992B Isoquinolinium compound or salts thereof, pharmaceutical composition containing the same, preparation and use thereof
12/08/2010CN101220035B A kind of alkaloid, method for preparing the same and application in antineoplastic or antimicrobial aspects
12/08/2010CN101107254B Heterocyclic tetracyclic tetrahydrofuran derivatives as 5HT2 inhibitors in the treatment of cns disorders
12/08/2010CN101087783B Trisubstituted thiophenes as progesterone receptor modulators
12/08/2010CN101033230B Cmptothecine derivative and application thereof
12/07/2010US7846935 Furo[3,2-B]pyrrol-3-one derivatives and their use as cysteinyl proteinase inhibitors
12/07/2010US7846934 N-((S)-1-cyclopentyl-2-oxo-2-((3aS,6aR)-3-oxodihydro-2H-furo[3,2-b]pyrrol-4(5H,6H,6aH)-yl)ethyl)-4-(4-methylpiperazin-1-yl)benzamide; osteoporosis, Paget's disease, Chagas's, malaria, gingival diseases, hypercalcemia, metabolic bone disease, bone cancer and associated pain
12/07/2010US7846927 N,N′-diphenylurea derivatives suitable as kinase inhibitors
12/07/2010CA2540248C Resolution of a narwedine amide derivative
12/02/2010WO2010138589A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010WO2010135914A1 New spiroheterocyclic furan and thiofuran dione derivatives
12/02/2010WO2010083384A3 Non-peptidyl, potent, and selective mu opioid receptor antagonists
12/02/2010US20100305322 Process for the Oxidation of Secondary Amines into the Corresponding Nitroxides
12/02/2010US20100305177 Prophylactic or therapeutic agent for diabetic maculopathy
12/02/2010US20100305149 Polyal Drug Conjugates Comprising Variable Rate-Releasing Linkers
12/02/2010US20100305148 Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
12/02/2010US20100305146 Method for the Production of 1,3-Dioxolane-2-Ones and Carboxylic Acid Esters by Means of Transacylation in Basic Reaction Conditions
12/02/2010US20100305115 Inhibitors of human immunodeficiency virus replication
12/02/2010US20100305097 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
12/02/2010CA2761445A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/01/2010EP1824857B1 Use of centrifugal partition chromatography for purifying galanthamine
12/01/2010EP1368342B3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/01/2010CN1982313B Camptothecin compound containing multiple organic hydroxy-acid group on 10-bit substituent, its production and composition
12/01/2010CN101903343A Compounds for inhibiting KSP kinesin activity
12/01/2010CN101899051A 1-azaxanthone-3-formamide compounds as well as preparation method and antitumor application thereof
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 298